Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 2/20 | 0.52 |
| ▸ | HTR2C | P28335 | 2/20 | 0.52 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.52 |
| ▸ | HSD11B1 | P28845 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | GAA | P10253 | 2/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | PKM | P14618 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | GRIN2B | Q13224 | 5/20 | 0.47 |
| ▸ | GRIN1 | Q05586 | 3/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | RECQL | P46063 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1122016 | 0.94 | HTR2A (0.47) | HTR2AHTR2CKCNH2HSD11B1ALDH1A1 | |
| SCHEMBL1121710 | 0.94 | HTR2A (0.47) | HTR2AHTR2CKCNH2HSD11B1ALDH1A1 | |
| SCHEMBL1121987 | 0.93 | HTR2A (0.58) | HTR2AHTR2CKCNH2HSD11B1ALDH1A1 | |
| SCHEMBL1121499 | 0.91 | GRIN2B (0.46) | HTR2AHTR2CKCNH2HSD11B1ALDH1A1 | |
| SCHEMBL1121743 | 0.90 | ALDH1A1 (0.47) | HTR2AHTR2CKCNH2ALDH1A1GAA | |
| SCHEMBL1121701 | 0.86 | HSD11B1 (0.45) | HTR2AHTR2CKCNH2HSD11B1ALDH1A1 | |
| SCHEMBL1121785 | 0.86 | HTR2A (0.48) | HTR2AHTR2CKCNH2HSD11B1ALDH1A1 | |
| SCHEMBL5803445 | 0.85 | DRD2 (0.57) | HTR2AKCNH2TSHRCYP2D6KDM4E | |
| SCHEMBL5827109 | 0.85 | GRIN2B (0.47) | HTR2AHTR2CKCNH2HSD11B1ALDH1A1 | |
| SCHEMBL5827146 | 0.85 | HTR2A (0.49) | HTR2AHTR2CKCNH2HSD11B1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070299048-A1 | Combination of Gaboxadol and 5Ht2 Antagonists | H. LUNDBECK A/S (DK) | 2007-12-27 | — | — | US | claimed |
| US-7094777-B2 | 5-HT2A receptor ligands | MERK SHARP & DOHME LTD. | 2006-08-22 | — | — | US | claimed |
| US-20050101586-A1 | Novel 5-HT2A receptor ligands | MERCK SHARP & DOHME LTD. (GB) | 2005-05-12 | — | — | US | claimed |
| EP-1685100-B1 | NOVEL 1, 3-DISUBSTITUTED AZETIDINE DERIVATIVES FOR USE AS 5HT2A RECEPTOR LIGANDS | MERCK SHARP & DOHME (GB) | 2011-02-09 | — | — | EP | disclosed |
| US-20070299048-A1 | Combination of Gaboxadol and 5Ht2 Antagonists | H. LUNDBECK A/S (DK) | 2007-12-27 | — | — | US | disclosed |
| US-20070203119-A1 | Combination Therapy For The Treatment Of Schizophrenia | MERCK SHARPE & DOHME LIMITED (GB) | 2007-08-30 | — | — | US | disclosed |
| US-7094777-B2 | 5-HT2A receptor ligands | MERK SHARP & DOHME LTD. | 2006-08-22 | — | — | US | disclosed |
| US-20050101586-A1 | Novel 5-HT2A receptor ligands | MERCK SHARP & DOHME LTD. (GB) | 2005-05-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050101586-A1 | Novel 5-HT2A receptor ligands | HTR2A, HTR1A, HTR5A | HTR2A 1/4885HTR2C 4/4885KCNH2 651/4885 |
| US-20070299048-A1 | Combination of Gaboxadol and 5Ht2 Antagonists | HTR2C, HTR2A, HTR3B | HTR2A 2/4885HTR2C 1/4885KCNH2 639/4885 |
| US-20070203119-A1 | Combination Therapy For The Treatment Of Schizophrenia | HTR3B, HTR3A, TACR2 | HTR2A 4/4885HTR2C 7/4885KCNH2 173/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.